$ADCT
ADC Therapeutics SA Stock $adct

$adct Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024034999 Filed on August 06, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2023 Q2
Revenue	$18.46M	$17.41M	$19.28M
YoY Change	27.4%	-9.71%	11.52%
Cost Of Revenue	$851.0K	$1.217M	$593.0K
YoY Change	132.51%	105.23%	46.78%
Gross Profit	$17.61M	$16.19M	$18.69M
YoY Change	24.68%	-13.36%	10.68%
Gross Profit Margin	95.39%	93.01%	96.92%
Selling, General & Admin	$20.68M	$20.94M	$25.75M
YoY Change	-10.25%	-18.68%	-28.15%
% of Gross Profit	117.38%	129.31%	137.76%
Research & Development	$32.50M	$24.30M	$31.55M
YoY Change	20.7%	-23.0%	-34.08%
% of Gross Profit	184.53%	150.03%	168.82%
Depreciation & Amortization	$336.0K	$326.0K	$769.0K
YoY Change	-57.79%	-57.61%	31.23%
% of Gross Profit	1.91%	2.01%	4.11%
Operating Expenses	$53.18M	$45.23M	$57.75M
YoY Change	5.5%	-21.68%	-31.25%
Operating Profit	-$35.56M	-$29.04M	-$39.06M
YoY Change	-1.97%	-25.66%	-41.8%
Interest Expense	$13.12M	$12.68M	-$14.21M
YoY Change	-218.9%	-189.2%	-457.49%
% of Operating Profit
Other Income/Expense, Net	-$8.055M	-$6.672M	$315.0K
YoY Change	-3401.23%	-2218.1%	176.32%
Pretax Income	-$43.60M	-$35.70M	-$53.73M
YoY Change	-8.96%	-33.55%	-17.75%
Income Tax	$100.0K	$200.0K	-$6.610M
% Of Pretax Income
Net Earnings	-$43.97M	-$36.54M	-$47.12M
YoY Change	-8.03%	-22.44%	-26.81%
Net Earnings / Revenue	-238.13%	-209.9%	-244.34%
Basic Earnings Per Share	-$0.42	-$0.38	-$0.60
Diluted Earnings Per Share	-$0.42	-$0.38	-$0.58
COMMON SHARES
Basic Shares Outstanding	96.65M shares	82.81M shares	81.47M shares
Diluted Shares Outstanding	104.8M shares	95.69M shares	81.47M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$274.3M	$300.1M	$347.5M
YoY Change	-11.64%	-13.64%	-7.77%
Cash & Equivalents	$274.3M	$300.1M	$347.5M
Short-Term Investments
Other Short-Term Assets	$18.63M	$17.18M	$22.00M
YoY Change	-12.46%	-21.92%	81.09%
Inventory	$16.07M	$15.19M	$19.43M
Prepaid Expenses
Receivables	$24.03M	$22.87M	$23.87M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$333.0M	$355.4M	$412.8M
YoY Change	-11.34%	-13.92%	-2.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.721M	$5.483M	$16.37M
YoY Change	-63.17%	-66.51%	68.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$260.0K	$28.32M
YoY Change	-100.0%	-99.08%	-23.07%
Other Assets	$1.165M	$992.0K	$36.27M
YoY Change	-96.8%	-97.26%	3.8%
Total Long-Term Assets	$16.07M	$16.42M	$94.49M
YoY Change	-82.39%	-82.62%	-1.59%
TOTAL ASSETS
Total Short-Term Assets	$333.0M	$355.4M	$412.8M
Total Long-Term Assets	$16.07M	$16.42M	$94.49M
Total Assets	$349.1M	$371.8M	$507.3M
YoY Change	-25.23%	-26.71%	-2.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.37M	$10.71M	$11.69M
YoY Change	60.1%	-8.41%	-10.2%
Accrued Expenses	$53.31M	$46.92M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$15.49M
YoY Change			107.07%
Total Short-Term Liabilities	$67.68M	$57.63M	$80.58M
YoY Change	-13.46%	-28.48%	9.36%
LONG-TERM LIABILITIES
Long-Term Debt	$436.8M	$429.9M	$407.4M
YoY Change	5.75%	5.52%	35.68%
Other Long-Term Liabilities	$7.649M	$6.624M	$27.91M
YoY Change	-74.35%	-76.27%	-10.47%
Total Long-Term Liabilities	$7.649M	$6.624M	$435.3M
YoY Change	-98.27%	-98.48%	31.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$67.68M	$57.63M	$80.58M
Total Long-Term Liabilities	$7.649M	$6.624M	$435.3M
Total Liabilities	$521.0M	$503.4M	$515.9M
YoY Change	-0.01%	-2.41%	27.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.463B	-$1.419B
YoY Change
Common Stock	$8.233M	$8.233M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$222.0K	$239.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	-$171.9M	-$131.7M	-$8.589M
YoY Change
Total Liabilities & Shareholders Equity	$349.1M	$371.8M	$507.3M
YoY Change	-25.23%	-26.71%	-2.53%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2023 Q2
OPERATING ACTIVITIES
Net Income	-$43.97M	-$36.54M	-$47.12M
YoY Change	-8.03%	-22.44%	-26.81%
Depreciation, Depletion And Amortization	$336.0K	$326.0K	$769.0K
YoY Change	-57.79%	-57.61%	31.23%
Cash From Operating Activities	-$25.04M	-$32.85M	-$36.82M
YoY Change	-26.37%	-10.81%	-30.53%
INVESTING ACTIVITIES
Capital Expenditures	$216.0K	$30.00K	$1.212M
YoY Change	-67.22%	-97.52%	-249.81%
Acquisitions
YoY Change
Other Investing Activities			$200.0K
YoY Change			66.67%
Cash From Investing Activities	-$216.0K	-$30.00K	-$1.012M
YoY Change	-67.22%	-97.04%	46.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-879.0K	98.70M	74.74M
YoY Change	-61.85%	32.06%	-29758.33%
NET CHANGE
Cash From Operating Activities	-25.04M	-32.85M	-36.82M
Cash From Investing Activities	-216.0K	-30.00K	-1.012M
Cash From Financing Activities	-879.0K	98.70M	74.74M
Net Change In Cash	-26.14M	65.82M	36.90M
YoY Change	-29.31%	78.37%	-168.4%
FREE CASH FLOW
Cash From Operating Activities	-$25.04M	-$32.85M	-$36.82M
Capital Expenditures	$216.0K	$30.00K	$1.212M
Free Cash Flow	-$25.26M	-$32.88M	-$38.04M
YoY Change	-27.15%	-13.57%	-27.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	380000	usd
CY2023Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	86000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	585000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	125000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2024Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	380000	usd
CY2023Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	86000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	585000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	125000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q2	adc	Cost Of Revenue Net CostOfRevenueNet	1217000	usd
CY2023Q2	adc	Cost Of Revenue Net CostOfRevenueNet	1132000	usd
	adc	Cost Of Revenue Net CostOfRevenueNet	3727000	usd
	adc	Cost Of Revenue Net CostOfRevenueNet	1105000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24295000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31342000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50030000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	69717000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10701000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14456000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22091000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10238000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27505000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	58932000	usd
CY2024Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	380000	usd
CY2023Q2	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	86000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	585000	usd
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	125000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q2	adc	Cost Of Revenue Net CostOfRevenueNet	1217000	usd
CY2023Q2	adc	Cost Of Revenue Net CostOfRevenueNet	1132000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q2	adc	Cost Of Revenue Net CostOfRevenueNet	1217000	usd
CY2023Q2	adc	Cost Of Revenue Net CostOfRevenueNet	1132000	usd
	adc	Cost Of Revenue Net CostOfRevenueNet	3727000	usd
	adc	Cost Of Revenue Net CostOfRevenueNet	3727000	usd
	adc	Cost Of Revenue Net CostOfRevenueNet	1105000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24295000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31342000	usd
	adc	Cost Of Revenue Net CostOfRevenueNet	1105000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24295000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31342000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	69717000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10701000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14456000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22091000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10238000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27505000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	58932000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	98117000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	128134000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29041000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-39649000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62654000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3253000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2372000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6201000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4547000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	10309000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50030000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	69717000	usd
CY2024Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10701000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14456000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22091000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10238000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	58932000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	98117000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	128134000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29041000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-62654000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-89859000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3253000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2372000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6201000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4547000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	10309000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	98117000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	128134000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-29041000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-39649000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-89859000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3253000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2372000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6201000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4547000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	10309000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
	us-gaap	Interest Expense InterestExpense	20600000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
	us-gaap	Interest Expense InterestExpense	20600000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6672000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6672000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6672000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13004000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18815000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13004000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18815000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35713000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13004000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-18815000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20287000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35713000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35713000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52653000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81469000	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81140287	shares
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52653000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81469000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110146000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4498000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3980000	usd
CY2024Q2	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-35947000	usd
CY2023Q2	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-48155000	usd
	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-81866000	usd
	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-106166000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-597000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-767000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81140287	shares
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	40000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	79000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	170000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-61000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	311000	usd
CY2024Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-64000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-142000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-103000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-700000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52653000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81469000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110146000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4498000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	397000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3980000	usd
CY2024Q2	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-35947000	usd
CY2023Q2	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-48155000	usd
	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-81866000	usd
	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-106166000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-597000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-767000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81140287	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81140287	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	40000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	79000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	170000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	311000	usd
CY2024Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-64000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-142000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-103000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-700000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110146000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4498000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3980000	usd
CY2024Q2	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-35947000	usd
CY2023Q2	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-48155000	usd
	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-81866000	usd
	adc	Income Loss From Continuing Operations Before Equity Method Investments IncomeLossFromContinuingOperationsBeforeEquityMethodInvestments	-106166000	usd
CY2024Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-597000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-767000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89121783	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	40000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	79000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	170000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	311000	usd
CY2024Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-64000	usd
CY2023Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	130000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-142000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-103000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
CY2024Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-64000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-194449000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1988000	usd
CY2024Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	99460000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-131670000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-148249000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-61000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-142000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-103000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	323000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2146000	usd
	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	99974000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-131670000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28422000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	40000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	170000	usd
CY2023Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	130000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1118000	usd
CY2023Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	1118000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	79451000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	311000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-700000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1988000	usd
CY2024Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	99460000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-131670000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-148249000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-61000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-142000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-103000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	323000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2146000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-131670000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28422000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	40000	usd
CY2023Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	130000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1118000	usd
CY2023Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	1118000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	79451000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	79000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-700000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	425000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9192000	usd
	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	9617000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2024Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-64000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1988000	usd
CY2024Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	99460000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-131670000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-148249000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-61000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	323000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2146000	usd
	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	99974000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28422000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	170000	usd
CY2023Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	130000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1118000	usd
CY2023Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	1118000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	79451000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	79000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	311000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-700000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	425000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9192000	usd
	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	9617000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2146000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9192000	usd
CY2024Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-73000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-137000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-36681000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1988000	usd
CY2024Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	99460000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-131670000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-148249000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	81000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-61000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	-142000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-103000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-245000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-83395000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	323000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60506000	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	36925000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28422000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	40000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	170000	usd
CY2023Q2	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	130000	usd
CY2023Q2	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-444000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-49236000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1118000	usd
CY2023Q2	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	1118000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	79451000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	79000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	311000	usd
	adc	Other Comprehensive Income Loss Before Oci Equity Method Investment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeOCIEquityMethodInvestmentNetOfTaxPortionAttributableToParent	232000	usd
	us-gaap	Oci Equity Method Investment After Tax Parent OciEquityMethodInvestmentAfterTaxParent	-700000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-468000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108764000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	425000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9192000	usd
	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	9617000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5172000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2146000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	13790000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	5346000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	943000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	425000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9192000	usd
	adc	Stockholders Equity Excluding Oci Period Increase Decrease StockholdersEquityExcludingOCIPeriodIncreaseDecrease	9617000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-19696000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5172000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9192000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	5346000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	943000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1503000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
	us-gaap	Depreciation Depreciation	657000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1024000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	999000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	838000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-636000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	240000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2314000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-49089000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	50000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	859000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	287000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-200000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6083000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-687000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5732000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15588000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1028000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-714000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3017000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3102000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76940000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50380000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	561000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2228000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-561000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2228000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	61731000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	36925000	usd
	adc	Proceeds From Royalties Received Net Of Transaction Costs ProceedsFromRoyaltiesReceivedNetOfTransactionCosts	73102000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	323000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	99053000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73527000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	21552000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-31000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5172000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2146000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9192000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	13790000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	5346000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	943000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1503000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5288000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
	us-gaap	Depreciation Depreciation	657000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1024000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	999000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	838000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	240000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2314000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-49089000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	50000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	859000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4930000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	287000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-200000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-687000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5732000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15588000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1028000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-714000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3017000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3102000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76940000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	561000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2228000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-561000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2228000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	61731000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	36925000	usd
	adc	Proceeds From Royalties Received Net Of Transaction Costs ProceedsFromRoyaltiesReceivedNetOfTransactionCosts	0	usd
	adc	Proceeds From Royalties Received Net Of Transaction Costs ProceedsFromRoyaltiesReceivedNetOfTransactionCosts	73102000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	323000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	425000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	99053000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73527000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	21552000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20919000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-31000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278598000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	13790000	usd
	us-gaap	Amortization Of Advance Royalty AmortizationOfAdvanceRoyalty	5346000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	943000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1503000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
	us-gaap	Depreciation Depreciation	657000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1024000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	999000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	838000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-636000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	240000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2314000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-49089000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	50000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	859000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4930000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	287000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-200000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6083000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-687000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5732000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15588000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1028000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-714000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3017000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3102000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76940000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50380000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	561000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2228000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-561000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2228000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	61731000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	36925000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	adc	Proceeds From Royalties Received Net Of Transaction Costs ProceedsFromRoyaltiesReceivedNetOfTransactionCosts	0	usd
	adc	Proceeds From Royalties Received Net Of Transaction Costs ProceedsFromRoyaltiesReceivedNetOfTransactionCosts	73102000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	323000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	425000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	99053000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73527000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	21552000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20919000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-31000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326441000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1503000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5288000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
	us-gaap	Depreciation Depreciation	657000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1024000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	999000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1284000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2130000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	838000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-636000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	240000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-18000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2314000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-49089000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	50000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2400000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4930000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	287000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-200000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6083000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-687000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5732000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1028000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-714000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3017000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	3102000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76940000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50380000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	561000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2228000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-561000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2228000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	36925000	usd
	adc	Proceeds From Royalties Received Net Of Transaction Costs ProceedsFromRoyaltiesReceivedNetOfTransactionCosts	73102000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	323000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	425000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	99053000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	73527000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	21552000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	20919000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-31000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278598000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326441000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300119000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	347510000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7874000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	7635000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	5167000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-2569000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-6230000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	278598000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300119000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	347510000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7874000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7522000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	7635000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	5167000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-2569000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-6230000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	1225000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	270000	usd
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Business Segments NumberOfBusinessSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300100000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326441000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300119000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	347510000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7874000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7522000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	7635000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	5167000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-2569000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-6230000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	1225000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	270000	usd
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Business Segments NumberOfBusinessSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300100000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	300119000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	347510000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7874000	usd
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	5167000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-2569000	usd
	adc	Noncash Payment For Royalty Financing Transaction NoncashPaymentForRoyaltyFinancingTransaction	-6230000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	1225000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	270000	usd
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Business Segments NumberOfBusinessSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300100000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	1225000	usd
	adc	Transaction Costs Recorded In Accounts Payable And Other Current Liabilities TransactionCostsRecordedInAccountsPayableAndOtherCurrentLiabilities	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	270000	usd
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Subsidiaries NumberOfSubsidiaries	3	subsidiary
	adc	Number Of Business Segments NumberOfBusinessSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300100000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1134000	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1134000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	296000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	296000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15123000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16095000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	82000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15191000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16177000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1134000	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1134000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	296000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	296000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15123000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16095000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	82000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15191000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16177000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	727000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1134000	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1134000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	296000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	296000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15123000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16095000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	82000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15191000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	727000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1134000	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1134000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	296000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	296000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15123000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16095000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	82000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15191000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	16177000	usd
CY2024Q2	us-gaap	Inventory Write Down InventoryWriteDown	288000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1036000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	727000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	780000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10174000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9897000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4691000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4275000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5483000	usd
	us-gaap	Depreciation Depreciation	657000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	273000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	adc	Number Of Product Candidates Developed And Commercialized In Joint Venture NumberOfProductCandidatesDevelopedAndCommercializedInJointVenture	3	subsidiary
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10174000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9897000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4691000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4275000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5483000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	326000	usd
	us-gaap	Depreciation Depreciation	657000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	adc	Number Of Product Candidates Developed And Commercialized In Joint Venture NumberOfProductCandidatesDevelopedAndCommercializedInJointVenture	3	subsidiary
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000.0	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110100000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10174000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9897000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4691000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4275000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5483000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	326000	usd
	us-gaap	Depreciation Depreciation	657000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	273000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	adc	Number Of Product Candidates Developed And Commercialized In Joint Venture NumberOfProductCandidatesDevelopedAndCommercializedInJointVenture	3	subsidiary
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000.0	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110100000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10174000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9897000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4691000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4275000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5483000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5622000	usd
CY2024Q2	us-gaap	Depreciation Depreciation	326000	usd
	us-gaap	Depreciation Depreciation	657000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	273000	usd
	us-gaap	Depreciation Depreciation	536000	usd
	adc	Number Of Product Candidates Developed And Commercialized In Joint Venture NumberOfProductCandidatesDevelopedAndCommercializedInJointVenture	3	subsidiary
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000.0	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52700000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-35700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-81500000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000000.0	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52700000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110100000	usd
CY2024Q2	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	18304000	usd
CY2023Q4	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	24902000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	8088000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	12693000	usd
CY2024Q2	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	8180000	usd
CY2023Q4	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	1543000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1415000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1467000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10937000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11496000	usd
CY2024Q2	adc	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	46924000	usd
CY2023Q4	adc	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	52101000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	733568	shares
CY2024Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	113700000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	112700000	usd
CY2024Q2	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	18304000	usd
CY2023Q4	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	24902000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	8088000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	12693000	usd
CY2024Q2	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	8180000	usd
CY2023Q4	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	1543000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1415000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1467000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10937000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11496000	usd
CY2024Q2	adc	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	46924000	usd
CY2024Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	113700000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	112700000	usd
CY2024Q2	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	18304000	usd
CY2023Q4	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	24902000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	8088000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	12693000	usd
CY2024Q2	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	8180000	usd
CY2023Q4	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	1543000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1415000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1467000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10937000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11496000	usd
CY2024Q2	adc	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	46924000	usd
CY2023Q4	adc	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	52101000	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	733568	shares
CY2024Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	113700000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	112700000	usd
CY2024Q2	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	18304000	usd
CY2023Q4	adc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	24902000	usd
CY2024Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	8088000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	12693000	usd
CY2024Q2	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	8180000	usd
CY2023Q4	adc	Accrued Gross To Net Sales Adjustment Current AccruedGrossToNetSalesAdjustmentCurrent	1543000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1415000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10937000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11496000	usd
CY2024Q2	adc	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	46924000	usd
CY2024Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	113700000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	112700000	usd
CY2021Q3	adc	Royalty Purchase Agreement RoyaltyPurchaseAgreement	325000000	usd
CY2021Q3	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	225000000	usd
CY2023	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	75000000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Additional Proceeds From Sale Of Future Royalties IncreaseDecreaseToRoyaltyObligationAdditionalProceedsFromSaleOfFutureRoyalties	75000000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-8709000	usd
CY2023Q4	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	309613000	usd
	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-2569000	usd
	adc	Increase Decrease To Royalty Obligation Interest Expense IncreaseDecreaseToRoyaltyObligationInterestExpense	16359000	usd
	adc	Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet	-526000	usd
CY2024Q2	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	322877000	usd
	adc	Capital And Interest Guarantee Defined Benefit Plan CapitalAndInterestGuaranteeDefinedBenefitPlan	1
CY2021Q3	adc	Royalty Purchase Agreement RoyaltyPurchaseAgreement	325000000	usd
CY2021Q3	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	225000000	usd
CY2023	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	75000000	usd
CY2022Q4	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	222277000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Additional Proceeds From Sale Of Future Royalties IncreaseDecreaseToRoyaltyObligationAdditionalProceedsFromSaleOfFutureRoyalties	75000000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Transaction Costs IncreaseDecreaseToRoyaltyObligationTransactionCosts	1898000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-8709000	usd
	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-2569000	usd
	adc	Increase Decrease To Royalty Obligation Interest Expense IncreaseDecreaseToRoyaltyObligationInterestExpense	16359000	usd
	adc	Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet	-526000	usd
CY2024Q2	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	322877000	usd
	adc	Capital And Interest Guarantee Defined Benefit Plan CapitalAndInterestGuaranteeDefinedBenefitPlan	1
CY2024Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	183000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	275000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	347000	usd
CY2021Q3	adc	Royalty Purchase Agreement RoyaltyPurchaseAgreement	325000000	usd
CY2021Q3	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	225000000	usd
CY2023	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	75000000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Additional Proceeds From Sale Of Future Royalties IncreaseDecreaseToRoyaltyObligationAdditionalProceedsFromSaleOfFutureRoyalties	75000000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Transaction Costs IncreaseDecreaseToRoyaltyObligationTransactionCosts	1898000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Interest Expense IncreaseDecreaseToRoyaltyObligationInterestExpense	27915000	usd
	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-2569000	usd
	adc	Increase Decrease To Royalty Obligation Interest Expense IncreaseDecreaseToRoyaltyObligationInterestExpense	16359000	usd
	adc	Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet	-526000	usd
CY2024Q2	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	322877000	usd
	adc	Capital And Interest Guarantee Defined Benefit Plan CapitalAndInterestGuaranteeDefinedBenefitPlan	1
CY2024Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	183000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	275000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	347000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	37000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	149000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	59000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	83000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	165000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-40000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-40000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-81000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-79000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	227000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	223000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	352000	usd
CY2021Q3	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	225000000	usd
CY2023	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	75000000	usd
CY2022Q4	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	222277000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Additional Proceeds From Sale Of Future Royalties IncreaseDecreaseToRoyaltyObligationAdditionalProceedsFromSaleOfFutureRoyalties	75000000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Transaction Costs IncreaseDecreaseToRoyaltyObligationTransactionCosts	1898000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-8709000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Interest Expense IncreaseDecreaseToRoyaltyObligationInterestExpense	27915000	usd
CY2023	adc	Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet	-4972000	usd
CY2023Q4	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	309613000	usd
	adc	Increase Decrease To Royalty Obligation Royalty Payments IncreaseDecreaseToRoyaltyObligationRoyaltyPayments	-2569000	usd
	adc	Increase Decrease To Royalty Obligation Interest Expense IncreaseDecreaseToRoyaltyObligationInterestExpense	16359000	usd
	adc	Increase Decrease To Royalty Obligation Cumulative Catch Up Adjustment Other Net IncreaseDecreaseToRoyaltyObligationCumulativeCatchUpAdjustmentOtherNet	-526000	usd
CY2024Q2	adc	Deferred Royalty Obligation DeferredRoyaltyObligation	322877000	usd
	adc	Capital And Interest Guarantee Defined Benefit Plan CapitalAndInterestGuaranteeDefinedBenefitPlan	1
CY2024Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	183000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	275000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	347000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	149000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	59000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	165000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-79000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	183000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	275000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	347000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	447000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	37000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	149000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	83000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	118000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	165000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-79000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	121000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	223000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	352000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.08
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	13161000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	5617000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-3479000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	447000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	75000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	149000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	59000	usd
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	165000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-40000	usd
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	-79000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	121000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	227000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	223000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	352000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.08
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	13161000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	5617000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-791000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-3479000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	12121000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-1064000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-7886000	usd
CY2023Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	4362000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	5783000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-229000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-4182000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	5734000	usd
CY2022Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	3746000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	11399000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-877000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-8534000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	121000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	223000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	352000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.08
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	35463000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
CY2024Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	13161000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	5617000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	12121000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-1064000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-7886000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	4362000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-229000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	5734000	usd
CY2022Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	3746000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	11399000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-877000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-8534000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	5734000	usd
CY2024Q2	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2424000	usd
CY2023Q4	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2403000	usd
CY2024Q2	adc	Current And Accrued Expenses And Other Current Liabilities Sales Adjustment CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment	12084000	usd
CY2023Q4	adc	Current And Accrued Expenses And Other Current Liabilities Sales Adjustment CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment	8934000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.08
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q2	us-gaap	Revenues Revenues	17410000	usd
CY2023Q2	us-gaap	Revenues Revenues	19283000	usd
	us-gaap	Revenues Revenues	38275000	usd
CY2024Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	13161000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	5617000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-791000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-3479000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	12121000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-1064000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-7886000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q1	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	4362000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	11399000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-877000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-8534000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	5734000	usd
CY2024Q2	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2424000	usd
CY2023Q4	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2403000	usd
CY2024Q2	adc	Current And Accrued Expenses And Other Current Liabilities Sales Adjustment CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment	12084000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
CY2024Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3300000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	6200000	usd
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2400000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
	adc	Gross To Net Sales Adjustment Provision GrossToNetSalesAdjustmentProvision	12121000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-1064000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-7886000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-4182000	usd
CY2022Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	3746000	usd
	adc	Gross To Net Sales Adjustment Prior Period Adjustment GrossToNetSalesAdjustmentPriorPeriodAdjustment	-877000	usd
	adc	Gross To Net Sales Adjustment Credits And Payments GrossToNetSalesAdjustmentCreditsAndPayments	-8534000	usd
CY2023Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	5734000	usd
CY2024Q2	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2424000	usd
CY2023Q4	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2403000	usd
CY2023Q4	adc	Current And Accrued Expenses And Other Current Liabilities Sales Adjustment CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment	8934000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	6200000	usd
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2400000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4500000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	16359000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	11575000	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	5000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	10309000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
	us-gaap	Interest Expense InterestExpense	20600000	usd
CY2024Q2	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2424000	usd
CY2023Q4	adc	Trade And Other Current Receivables Sales Adjustment TradeAndOtherCurrentReceivablesSalesAdjustment	2403000	usd
CY2024Q2	adc	Current And Accrued Expenses And Other Current Liabilities Sales Adjustment CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment	12084000	usd
CY2023Q4	adc	Current And Accrued Expenses And Other Current Liabilities Sales Adjustment CurrentAndAccruedExpensesAndOtherCurrentLiabilitiesSalesAdjustment	8934000	usd
CY2024Q2	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	14508000	usd
CY2023Q4	adc	Gross To Net Sales Adjustment GrossToNetSalesAdjustment	11337000	usd
CY2024Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3300000	usd
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2400000	usd
CY2024Q2	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	8266000	usd
CY2023Q2	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	5829000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	16359000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	11575000	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	5000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	10309000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
	us-gaap	Interest Expense InterestExpense	20600000	usd
CY2024Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-263000	usd
CY2023Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5417000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5288000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-96000	usd
CY2024Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3300000	usd
CY2023Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2400000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4500000	usd
CY2024Q2	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	8266000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	16359000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	11575000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	5000	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	10309000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
	us-gaap	Interest Expense InterestExpense	20600000	usd
CY2024Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-263000	usd
CY2023Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5417000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5288000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-96000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-37000	usd
CY2024Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-320000	usd
CY2023Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-315000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-567000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-455000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4500000	usd
CY2024Q2	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	8266000	usd
CY2023Q2	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	5829000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	16359000	usd
	adc	Deferred Royalty Obligation Interest Expense DeferredRoyaltyObligationInterestExpense	11575000	usd
CY2024Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2024Q2	us-gaap	Interest Expense InterestExpense	12679000	usd
	us-gaap	Interest Expense InterestExpense	25175000	usd
	us-gaap	Interest Expense InterestExpense	20600000	usd
CY2024Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-263000	usd
CY2023Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5417000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5288000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-96000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-37000	usd
CY2024Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-320000	usd
CY2023Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-315000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-567000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-455000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
CY2024Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-263000	usd
CY2023Q2	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5417000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	-526000	usd
	adc	Deferred Royalty Obligation Cumulative Catch Up Adjustment DeferredRoyaltyObligationCumulativeCatchUpAdjustment	5288000	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-59000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-37000	usd
CY2024Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-320000	usd
CY2023Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-315000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-567000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.00
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10744406	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M20D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	540400	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	428200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	32.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	866595	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.62
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31988	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M7D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4910379	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	14.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y11M4D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.02
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5047644	shares
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-37000	usd
CY2024Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-320000	usd
CY2023Q2	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-315000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-567000	usd
	adc	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	-455000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2754000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5067000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	159000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4234000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.00
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10744406	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M20D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	540400	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	428200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	32.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	866595	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.62
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31988	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.23
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M7D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4910379	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	14.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y11M4D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.02
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5047644	shares
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9800000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.00
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10744406	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M20D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	540400	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	428200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	32.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	866595	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.62
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31988	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.23
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M7D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4910379	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	14.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y11M4D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.02
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5047644	shares
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9800000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.00
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10744406	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M20D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.83
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	540400	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	10.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	428200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	32.53
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	866595	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.62
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31988	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.23
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M7D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	4910379	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9958023	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	14.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y11M4D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5047644	shares
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9800000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9800000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81140287	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81140287	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81140287	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20688034	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17342313	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-48922000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81140287	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20688034	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17342313	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-36544000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-83150000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-108296000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95691245	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95691245	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81471127	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81471127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89121783	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81140287	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81140287	shares
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.93
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20688034	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17342313	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20688034	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17342313	shares
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-034999-index-headers.html	Edgar Link	pending
0001628280-24-034999-index.html	Edgar Link	pending
0001628280-24-034999.txt	Edgar Link	pending
0001628280-24-034999-xbrl.zip	Edgar Link	pending
adc-20240630.htm	Edgar Link	pending
adc-20240630.xsd	Edgar Link	pending
adc-20240630_g1.jpg	Edgar Link	pending
ex101adct-secondlimitedw.htm	Edgar Link	pending
ex101adct-secondlimitedw001.jpg	Edgar Link	pending
ex101adct-secondlimitedw002.jpg	Edgar Link	pending
ex101adct-secondlimitedw003.jpg	Edgar Link	pending
ex101adct-secondlimitedw004.jpg	Edgar Link	pending
ex101adct-secondlimitedw005.jpg	Edgar Link	pending
ex101adct-secondlimitedw006.jpg	Edgar Link	pending
ex101adct-secondlimitedw007.jpg	Edgar Link	pending
ex101adct-secondlimitedw008.jpg	Edgar Link	pending
ex101adct-secondlimitedw009.jpg	Edgar Link	pending
ex101adct-secondlimitedw010.jpg	Edgar Link	pending
ex101adct-secondlimitedw011.jpg	Edgar Link	pending
ex101adct-secondlimitedw012.jpg	Edgar Link	pending
ex101adct-secondlimitedw013.jpg	Edgar Link	pending
adc-20240630_cal.xml	Edgar Link	unprocessable
adc-20240630_def.xml	Edgar Link	unprocessable
adc-20240630_lab.xml	Edgar Link	unprocessable
adc-20240630_pre.xml	Edgar Link	unprocessable
adc-20240630_htm.xml	Edgar Link	completed
ex311-ceocertification302q.htm	Edgar Link	pending
ex312-cfocertification302q.htm	Edgar Link	pending
ex321-ceocertification906q.htm	Edgar Link	pending
ex322-cfocertification906q.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
0001628280-24-034999-index-headers.html	Edgar Link	pending
0001628280-24-034999-index.html	Edgar Link	pending
0001628280-24-034999.txt	Edgar Link	pending
0001628280-24-034999-xbrl.zip	Edgar Link	pending
adc-20240630.htm	Edgar Link	pending
adc-20240630.xsd	Edgar Link	pending
adc-20240630_g1.jpg	Edgar Link	pending
ex101adct-secondlimitedw.htm	Edgar Link	pending
ex101adct-secondlimitedw001.jpg	Edgar Link	pending
ex101adct-secondlimitedw002.jpg	Edgar Link	pending
ex101adct-secondlimitedw003.jpg	Edgar Link	pending
ex101adct-secondlimitedw004.jpg	Edgar Link	pending
ex101adct-secondlimitedw005.jpg	Edgar Link	pending
ex101adct-secondlimitedw006.jpg	Edgar Link	pending
ex101adct-secondlimitedw007.jpg	Edgar Link	pending
ex101adct-secondlimitedw008.jpg	Edgar Link	pending
ex101adct-secondlimitedw009.jpg	Edgar Link	pending
ex101adct-secondlimitedw010.jpg	Edgar Link	pending
ex101adct-secondlimitedw011.jpg	Edgar Link	pending
ex101adct-secondlimitedw012.jpg	Edgar Link	pending
ex101adct-secondlimitedw013.jpg	Edgar Link	pending
adc-20240630_cal.xml	Edgar Link	unprocessable
adc-20240630_def.xml	Edgar Link	unprocessable
adc-20240630_lab.xml	Edgar Link	unprocessable
adc-20240630_pre.xml	Edgar Link	unprocessable
adc-20240630_htm.xml	Edgar Link	completed
ex311-ceocertification302q.htm	Edgar Link	pending
ex312-cfocertification302q.htm	Edgar Link	pending
ex321-ceocertification906q.htm	Edgar Link	pending
ex322-cfocertification906q.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ADCT
ADC Therapeutics SA Stock $adct

2024 Q3 Form 10-Q Financial Statement

#000162828024034999 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADCT ADC Therapeutics SA Stock $adct

2024 Q3 Form 10-Q Financial Statement

#000162828024034999 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADCT
ADC Therapeutics SA Stock $adct